Maverick Capital’s Zimmer Biomet ZBH Stock Holding History

Maverick Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-729	Closed	-$90K	–	392
2021 Q4	$90K	Sell	729 -20,082	-96%	-$2.63M	﹤0.01%	231
2021 Q3	$2.96M	Buy	20,811 +11,582	+125%	+$1.7M	0.03%	143
2021 Q2	$1.44M	Sell	9,229 -9,990	-52%	-$1.62M	0.01%	206
2021 Q1	$2.99M	Buy	19,219 +12,844	+201%	+$1.99M	0.03%	112
2020 Q4	$954K	Buy	6,375 +945	+17%	+$133K	0.02%	237
2020 Q3	$718K	Buy	5,430 +2,231	+70%	+$291K	0.01%	365
2020 Q2	$371K	Buy	+3,199	New	+$369K	0.01%	478
2019 Q3	–	Sell	-38,337	Closed	-$4.38M	–	407
2019 Q2	$4.38M	Buy	+38,337	New	+$4.49M	0.06%	181

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital's ZBH Position: Q1 2022 in Review

Maverick Capital sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 729 shares — an estimated $90K sold.

Maverick Capital first reported a position in ZBH in Q2 2019 and held it in 8 quarters. The position peaked at $4.38M in Q2 2019. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Maverick Capital reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Maverick Capital sold 729 Zimmer Biomet shares in Q1 2022, an estimated $90K.
Maverick Capital first reported a position in Zimmer Biomet in Q2 2019 and held it in 8 quarters.
Maverick Capital's Zimmer Biomet position peaked at $4.38M in Q2 2019.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Maverick Capital's 13F filing for Q1 2022, filed 16 May 2022.